Literature DB >> 28219659

Dementia-like pathology in type-2 diabetes: A novel microRNA mechanism.

Anuradha Kalani1, Pankaj Chaturvedi2, Claudio Maldonado3, Philip Bauer4, Irving G Joshua2, Suresh C Tyagi2, Neetu Tyagi2.   

Abstract

Although type-2 diabetes (T2D) has been reported to increase the risk of cognitive dysfunction and dementia, the underlying mechanisms remain unclear. Dementia-like pathology is attributed to the accumulation of cellular prion protein (PrPc) which plays a role in cognitive dysfunction. However, its involvement and regulation in diabetic dementia-like pathology is not well understood. Using T2D db/db (leptin receptor knockout) mice subjected to object recognition and Y-maze behavioral tests, we determined that short-term memory was compromised and that the mice displayed abrupt spontaneous behaviour compared to db/m control mice. MicroRNA analysis using qRT2-PCR array demonstrated a significant reduction in the transcript expression of microRNA-146a (miR-146a) in the brain of T2D db/db mice as compared to db/m controls. The sequence matching tools validated the binding of miR-146a to a conserved domain of the PrPc gene. Administration of mouse brain endothelial cell-derived exosomes (BECDEs) loaded with miR-146a into the brain's ventricle of T2D db/db mice attenuated brain PrPc levels and restored short-term memory function though not significant. Also, we observed hyperphosphorylation of tau through decreased expression of glycogen synthase kinase-3 in T2D db/db brains that regulates microtubule organization and memory function. We conclude that underexpression of miR-146a upregulates PrPc production in T2D db/db mice and the delivery of BECDEs loaded with a miR-146a can down regulate PrPc levels and restore short term memory function up to a certain extent.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cellular prion protein; Dementia; Diabetes; Memory; microRNA

Mesh:

Substances:

Year:  2017        PMID: 28219659      PMCID: PMC5432966          DOI: 10.1016/j.mcn.2017.02.005

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  35 in total

1.  Memory impairment in transgenic Alzheimer mice requires cellular prion protein.

Authors:  David A Gimbel; Haakon B Nygaard; Erin E Coffey; Erik C Gunther; Juha Laurén; Zachary A Gimbel; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

Review 2.  Vascular aspects of cognitive impairment and dementia.

Authors:  Maximilian Wiesmann; Amanda J Kiliaan; Jurgen A H R Claassen
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-11       Impact factor: 6.200

3.  Global prevalence of dementia: a Delphi consensus study.

Authors:  Cleusa P Ferri; Martin Prince; Carol Brayne; Henry Brodaty; Laura Fratiglioni; Mary Ganguli; Kathleen Hall; Kazuo Hasegawa; Hugh Hendrie; Yueqin Huang; Anthony Jorm; Colin Mathers; Paulo R Menezes; Elizabeth Rimmer; Marcia Scazufca
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

4.  Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy.

Authors:  Viktoriya Sokolova; Anna-Kristin Ludwig; Sandra Hornung; Olga Rotan; Peter A Horn; Matthias Epple; Bernd Giebel
Journal:  Colloids Surf B Biointerfaces       Date:  2011-05-12       Impact factor: 5.268

5.  Curcumin-loaded embryonic stem cell exosomes restored neurovascular unit following ischemia-reperfusion injury.

Authors:  Anuradha Kalani; Pankaj Chaturvedi; Pradip K Kamat; Claudio Maldonado; Philip Bauer; Irving G Joshua; Suresh C Tyagi; Neetu Tyagi
Journal:  Int J Biochem Cell Biol       Date:  2016-09-02       Impact factor: 5.085

6.  Diabetes is related to cerebral infarction but not to AD pathology in older persons.

Authors:  Z Arvanitakis; J A Schneider; R S Wilson; Y Li; S E Arnold; Z Wang; D A Bennett
Journal:  Neurology       Date:  2006-12-12       Impact factor: 9.910

Review 7.  Epidemiology of Alzheimer disease.

Authors:  Christiane Reitz; Carol Brayne; Richard Mayeux
Journal:  Nat Rev Neurol       Date:  2011-02-08       Impact factor: 42.937

8.  Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse.

Authors:  Erika Chung; Yong Ji; Yanjie Sun; Richard J Kascsak; Regina B Kascsak; Pankaj D Mehta; Stephen M Strittmatter; Thomas Wisniewski
Journal:  BMC Neurosci       Date:  2010-10-14       Impact factor: 3.288

9.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

Review 10.  Tau aggregation and its interplay with amyloid-β.

Authors:  Rebecca M Nisbet; Juan-Carlos Polanco; Lars M Ittner; Jürgen Götz
Journal:  Acta Neuropathol       Date:  2014-12-10       Impact factor: 17.088

View more
  12 in total

1.  Protective effects of losartan on some type 2 diabetes mellitus-induced complications in Wistar and spontaneously hypertensive rats.

Authors:  Daniela Pechlivanova; Ekaterina Krumova; Nedelina Kostadinova; Jeny Mitreva-Staleva; Petar Grozdanov; Alexander Stoynev
Journal:  Metab Brain Dis       Date:  2020-01-29       Impact factor: 3.584

Review 2.  Peripheral versus central insulin and leptin resistance: Role in metabolic disorders, cognition, and neuropsychiatric diseases.

Authors:  Jennifer M Erichsen; Jim R Fadel; Lawrence P Reagan
Journal:  Neuropharmacology       Date:  2021-11-08       Impact factor: 5.250

Review 3.  Diabetes complications and extracellular vesicle therapy.

Authors:  Setareh Soltani; Kamran Mansouri; Shahram Parvaneh; Avnesh S Thakor; Flemming Pociot; Reza Yarani
Journal:  Rev Endocr Metab Disord       Date:  2021-10-14       Impact factor: 6.514

4.  Disruption of Circadian Clocks Promotes Progression of Alzheimer's Disease in Diabetic Mice.

Authors:  Jiaojiao Huang; Xuemin Peng; Rongping Fan; Kun Dong; Xiaoli Shi; Shujun Zhang; Xuefeng Yu; Yan Yang
Journal:  Mol Neurobiol       Date:  2021-05-21       Impact factor: 5.590

Review 5.  Extracellular Vesicles as Protagonists of Diabetic Cardiovascular Pathology.

Authors:  Dakota Gustafson; Shawn Veitch; Jason E Fish
Journal:  Front Cardiovasc Med       Date:  2017-11-09

Review 6.  Noncoding RNAs Carried by Extracellular Vesicles in Endocrine Diseases.

Authors:  Margherita A C Pomatto; Chiara Gai; Maria Chiara Deregibus; Ciro Tetta; Giovanni Camussi
Journal:  Int J Endocrinol       Date:  2018-04-01       Impact factor: 3.257

Review 7.  Therapeutic Potentials of Extracellular Vesicles for the Treatment of Diabetes and Diabetic Complications.

Authors:  Wei Hu; Xiang Song; Haibo Yu; Jingyu Sun; Yong Zhao
Journal:  Int J Mol Sci       Date:  2020-07-21       Impact factor: 5.923

8.  Amyloidosis is associated with thicker myelin and increased oligodendrogenesis in the adult mouse brain.

Authors:  Solène Ferreira; Kimberley A Pitman; Shiwei Wang; Benjamin S Summers; Nicole Bye; Kaylene M Young; Carlie L Cullen
Journal:  J Neurosci Res       Date:  2020-06-18       Impact factor: 4.164

Review 9.  Mitochondrial Dysfunction and Mitophagy Closely Cooperate in Neurological Deficits Associated with Alzheimer's Disease and Type 2 Diabetes.

Authors:  Sangita Paul; Debarpita Saha; Binukumar Bk
Journal:  Mol Neurobiol       Date:  2021-04-01       Impact factor: 5.590

Review 10.  Role of Mitochondrial Stress Protein HSP60 in Diabetes-Induced Neuroinflammation.

Authors:  Donisha Shani Niharika Keembiya Liyanagamage; Ryan D Martinus
Journal:  Mediators Inflamm       Date:  2020-04-17       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.